Belatacept Biosimilar

Belatacept Biosimilar

$400.00$1,600.00

In stock

$400.00$1,600.00

Belatacept Biosimilar. Nulojix biosimilar CHO stable cell line is available for licensing to manufacture the belatacept biosimilar protein.The research grade belatacept biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls and recombinant hIgG1 Fc proteins are available.

SKU: C008P
Clear
View cart
Catalog No. C008P
Product NameBelatacept Biosimilar
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Synonyms Nulojix, CTLA-4 Fc Fusion Protein
Summary Recombinant protein composed of the extracellular domain of CTLA-4 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1).
Source/Host The belatacept biosimilar protein was produced in the Nulojix biosimilar CHO stable cell line.
Specificity/Sensitivity The belatacept biosimilar protein specifically binds to the human CD80 (B7-1) with more avidity than to CD86 (B7-2).
Form Of Antibody 0.2 uM filtered solution, pH 7.2 to 7.8, no stabilizers or preservatives.
Endotoxin <1 EU/mg of the protein by the LAL method.
Purity >95% by SDS-PAGE under reducing conditions and HPLC.
Shipping The belatacept biosimilar protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note Nulojix biosimilar CHO stable cell line is available for licensing to manufacture the belatacept biosimilar protein.The research grade belatacept biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls and recombinant hIgG1 Fc proteins are available.
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C008P: Belatacept Biosimilar

Belatacept (trade name Nulojix, Bristol-Myers-Squibb), a fusion protein of a Fc fragment (human IgG1 isotype) and the extracellular domain of CTLA-4, can be used to extend graft survival while limiting the toxicity generated by standard immune suppressing regimens, such as calcineurin inhibitors. Belatacept differs from abatacept (trade name Orencia) by only 2 amino acids.

The CTLA-4 protein is important for T-cell costimulation and selectively blocks the process of T-cell activation.

Syd Labs also provides the following CTLA-4 Fc Fusion Protein biosimilar:
Abatacept Biosimilar

Syd Labs provides the following research grade anti-CTLA-4 antibody biosimilars:
Ipilimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody
Tremelimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody

Please remember our product information: Belatacept Biosimilar: C008P Syd Labs

Additional information

Ship from Country

USA

Size

1 mg, 20 mg, 5 mg

No more offers for this product!